Literature DB >> 20610121

Fetal alcohol syndrome, Tourette syndrome, and hyperactivity in nine adopted children.

Daniel Martín Fernández-Mayoralas1, Alberto Fernández-Jaén, Nuria Muñoz-Jareño, Beatriz Calleja Pérez, Rafael Arroyo-González.   

Abstract

Much attention has been paid in recent years to the role of prenatal exposure to alcohol. Fetal alcohol syndrome is one of the most severe afflictions resulting from such exposure. The present report documents the cases of adopted children diagnosed with fetal alcohol syndrome who developed both Tourette syndrome and attention deficit-hyperactivity disorder. Out of a population of 138 adopted children with behavior issues whose clinical histories were reviewed retrospectively, 9 children (6.5%) presented this constellation. Epidemiologic data, clinical data, neurologic examination findings, complementary testing, and developmental data were recorded. All nine patients studied had initial psychomotor retardation, despite the frequent case of subsequent intelligence quotient normalization. From a behavioral perspective, half of the cases presented obsessive-compulsive disorder and problems with social relations. Aggressive behavior was common. These cases also presented a high degree of severity of both tics and hyperactivity. The most common drug treatment was methylphenidate. This constellation of fetal alcohol syndrome, Tourette syndrome, and attention deficit-hyperactivity disorder is scantly reported in the literature and is likely underdiagnosed. This particular constellation poses its own prognosis and requires its own treatment. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20610121     DOI: 10.1016/j.pediatrneurol.2010.03.008

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  1 in total

Review 1.  Prenatal risk factors for Tourette Syndrome: a systematic review.

Authors:  Ting-Kuang Chao; Jing Hu; Tamara Pringsheim
Journal:  BMC Pregnancy Childbirth       Date:  2014-01-30       Impact factor: 3.007

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.